Science
Innovative Bioreactor Produces Immune Cells Efficiently
A new method developed by researchers at Hannover Medical School enables the efficient production of human macrophages from stem cells, potentially revolutionizing immune cell therapy.
Editorial Staff
1 min read
Updated 13 days ago
Researchers at Hannover Medical School have made significant advancements in the production of human immune cells, specifically macrophages, using medium-sized bioreactors.
This innovative method allows for the generation of up to 40 million macrophages each week, derived from induced pluripotent stem cells.
The implications of this research could be substantial, potentially enhancing the availability of immune cells for therapeutic applications.